About this trial
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Eligibility criteria
Qualifiers
18 years or older
willing and able to provide informed consent
postoperative urinary retention as defined by a failed RGVT prior to hospital discharge
Ability to speak and read English
Disqualifiers
allergy/intolerance to Tamsulosin or sulfa drugs
preoperative history of urinary retention as defined by preoperative post void residual of >150mL
current use of alpha antagonist medication for hypertension
severe dementia
Trial design
Treatments tested in this trial
- Tamsulosin
- Placebo
Treatment groups
Sponsors and collaborators
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Lead sponsor
Johns Hopkins University
Collaborator